论文部分内容阅读
目的观察养血饮联合促红细胞生成素(EPO)对维持性血液透析患者Hb、Hct、T淋巴细胞亚群的影响。方法 60例维持性血液透析伴肾性贫血(RA)的患者,随机分成中西药组30例,养血饮联合EPO治疗;西药组30例,单用EPO治疗;治疗3个月后观察疗效。结果中西药组CD4、CD4/CD8的改善明显优于西药组(P<0.05),Hct、Hb两组无统计学差异(P>0.05)。在改善临床症状方面,中西药组疗效明显优于西药组(P>0.05)。结论养血饮联合EPO能改善T淋巴细胞亚群功能和临床症状。
Objective To observe the effects of Yangxueyin combined with erythropoietin (EPO) on Hb, Hct and T lymphocyte subsets in maintenance hemodialysis patients. Methods Sixty patients with maintenance hemodialysis and renal anemia (RA) were randomly divided into Chinese and western medicine group (n = 30) and Yangxueyin combined with EPO (n = 30). Western medicine group (n = 30) was treated with EPO alone. Results The improvement of CD4, CD4 / CD8 in Chinese and Western medicine groups was significantly better than that in western medicine group (P <0.05). There was no significant difference between Hct and Hb groups (P> 0.05). In improving clinical symptoms, Chinese and Western medicine group was significantly better than western medicine group (P> 0.05). Conclusion Yangxue Yin combined with EPO can improve the function and clinical symptoms of T lymphocyte subsets.